ISSN:
1573-739X
Keywords:
Chemistry, pharmaceutical
;
Computers
;
Drug development
;
Molecular biology
;
Research
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Notes:
Abstract Classical medicinal chemistry, that is molecular modifications of existing bioactive compounds, leading to me-too drugs with value added and often to me-too drugs which will never reach the market or to drugs in another pharmacological field than that originally intended, will be with us for a long time to come. The ultimate goal, however, is of course rational or at least semi-rational drug design. In some instances this goal seems to have already been reached as in the case of angiotensin-converting enzyme inhibitors and H2 antagonists. In the (near) future results from the steady progress in molecular biology in combination with computer-assisted drug modelling — possibly coupled with artificial intelligence techniques — will help the medicinal chemist in his efforts to attain this goal.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF01957740
Permalink
